Helen Thackray Net Worth & Insider Trades

Helen Thackray - SVP Clinical Development, Glycomimetics Inc

As of January 22, 2021

What is Helen Thackray's Net Worth?

The current estimated net worth of Glycomimetics Inc's SVP Clinical Development, Helen Thackray, is estimated to be about $2.09M . Helen Thackray owns about 148,615 units of Glycomimetics Inc common stock. In the last 7 years at Glycomimetics Inc, Helen Thackray has sold an estimated value of $309.39K worth.

What is Helen Thackray's Past Insider Trading?

Helen Thackray's largest sale order was 22,000 units , worth over $153.95K on July 6, 2016. In total, Helen Thackray has made about 15 transactions over 7 years of their time at Glycomimetics Inc. Helen Thackray usually trades in January, with the busiest year in 2017. The most recent transaction was a sale order of 2,000 units , worth over $30.02K on December 12, 2017.

Helen Thackray

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Helen Thackray's' Mailing Address?

  • Mailing address is C/o Glycomimetics, Inc. 401 Professional Drive, Suite 250 Gaithersburg MD 20879 MD

What are Glycomimetics Inc's Past Insider Trades?

Glycomimetics Inc's most recent insider trade came on January 27, 2023 by Scott Sandell who sold 3,652,016 units worth $11.48M . In the last 9 years, insiders at Glycomimetics Inc have sold an estimated value of $15.15M and bought an estimated value of $45.76M worth of shares. Insider trading is most common in January, with the busiest year in 2014. The most active traders at the company are John Magnani, SVP Research,  Brian Hahn, SVP Finance,  and Helen Thackray, SVP Clinical Development .

GLYCOMIMETICS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1